While there were no statistically significant differences between both survival groups in the estimated abundance of CD8+ T cells (P = 0.36), that of CD3+ T cells and B lineage cells was significantly higher in LTS vs. STS-cases (P = 0.006 and 0.036, respectively). The gene discussed is CD8A; the disease is telomere syndrome.